Patents by Inventor Cezary Cybulski

Cezary Cybulski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110105342
    Abstract: The invention provide methods for early detection of a reduced risk of developing cancer, which comprises detecting the absence of a series of genetic polymorphisms associated with a predisposition of developing cancer, including the polymorphisms of the genes BRCA1, BRCA2, CARD15 (NOD2), CHEK2, CDKN2A (P16), CYP1B1, FGFR2 (KGFR2), MAP3K1 (MEKK1), p53 (TP53), TNRC9, XPD (ERCC2) and the genetic marker Rs6983267, in a biological sample from the analyzed subject, wherein the absence of the genetic polymorphisms is indicative of significantly decreased risk of developing, at least, breast cancer.
    Type: Application
    Filed: March 13, 2009
    Publication date: May 5, 2011
    Inventors: Jan Lubinski, Tadeusz Debniak, Grzegorz Kurzawski, Anna Jakubowska, Krzystof Medrek, Cezary Cybulski, Jacek Gronwald, Tomasz Huzarski, Bohdan Gorski, Tomasz Byrski, Joanna Matyjasik, Pablo Serrano Fernandez
  • Patent number: 7851162
    Abstract: The present invention relates to methods and kits for determining a predisposition and surveillance protocols for developing cancer of various sites due to specific mutation in at least one allele of CHEK2 gene and/or at least one allele of NOD2 gene and/or at least one allele of CDKN2A gene.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: December 14, 2010
    Inventors: Jan Lubiñski, Janina Suchy, Grzegorz Kurzawski, Tadeusz Dêbniak, Cezary Cybulski
  • Patent number: 7745133
    Abstract: The present invention relates to methods and kits for determining a predisposition for developing cancer, e.g., prostate and/or breast cancer, due to a germline mutation of a NBS1 gene. The present invention also relates to surveillance protocols for developing cancer, e.g., prostate and/or breast cancer, due to germline mutation of a NBS1 gene.
    Type: Grant
    Filed: December 5, 2007
    Date of Patent: June 29, 2010
    Assignee: Pomeranian Academy of Medicine
    Inventors: Cezary Cybulski, Jan Lubinski, Bohdan Gorski, Bartlomiej Gliniewicz, Andrzej Sikorski, Tomasz Huzarski, Tadeusz Debniak, Jacek Gronwald, Tomasz Byrski
  • Publication number: 20090197255
    Abstract: The present invention relates to methods and kits for determining a predisposition for developing cancer, e.g., prostate and/or breast cancer, due to a germline mutation of a NBS1 gene. The present invention also relates to surveillance protocols for developing cancer, e.g., prostate and/or breast cancer, due to germline mutation of a NBS1 gene.
    Type: Application
    Filed: December 5, 2007
    Publication date: August 6, 2009
    Inventors: Cezary Cybulski, Jan Lubinski, Bohdan Gorski, Bartlomiej Gliniewicz, Andrzej Sikorski, Tomasz Huzarski, Tadeusz Debniak, Jacek Gronwald, Tomasz Byrski
  • Publication number: 20090092984
    Abstract: The present invention relates to methods and kits for determining a predisposition and surveillance protocols for developing cancer of various sites due to specific mutation in at least one allele of CHEK2 gene and/or at least one allele of NOD2 gene and/or at least one allele of CDKN2A gene.
    Type: Application
    Filed: July 28, 2008
    Publication date: April 9, 2009
    Inventors: Jan Lubinski, Janina Suchy, Grzegorz Kurzawski, Tadeusz Debniak, Cezary Cybulski
  • Patent number: 7407755
    Abstract: The present invention relates to methods and kits for determining a predisposition and surveillance protocols for developing cancer of various sites due to specific mutation in at least one allele of CHEK2 gene and/or at least one allele of NOD2 gene and/or at least one allele of CDKN2A gene.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: August 5, 2008
    Inventors: Jan Lubiñski, Janina Suchy, Grzegorz Kurzawski, Tadeusz Dêbniak, Cezary Cybulski
  • Patent number: 7319007
    Abstract: The present invention relates to methods and kits for determining a predisposition for developing cancer, e.g., prostate and/or breast cancer, due to a germline mutation of a NBS1 gene. The present invention also relates to surveillance protocols for developing cancer, e.g., prostate and/or breast cancer, due to germline mutation of a NBS1 gene.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: January 15, 2008
    Assignee: Pomeranian Academy of Medicine
    Inventors: Cezary Cybulski, Jan Lubinski, Bohdan Gorski, Bartlomiej Gliniewicz, Andrzej Sikorski, Tomasz Huzarski, Tadeusz Debniak, Jacek Gronwald, Tomasz Byrski
  • Publication number: 20050191669
    Abstract: The present invention relates to methods and kits for determining a predisposition and surveillance protocols for developing cancer of various sites due to specific mutation in at least one allele of CHEK2 gene and/or at least one allele of NOD2 gene and/or at least one allele of CDKN2A gene.
    Type: Application
    Filed: January 18, 2005
    Publication date: September 1, 2005
    Inventors: Jan Lubinski, Janina Suchy, Grzegorz Kurzawski, Tadeusz Debniak, Cezary Cybulski
  • Publication number: 20050064461
    Abstract: The present invention relates to methods and kits for determining a predisposition for developing cancer, e.g., prostate and/or breast cancer, due to a germline mutation of a NBS1 gene. The present invention also relates to surveillance protocols for developing cancer, e.g., prostate and/or breast cancer, due to germline mutation of a NBS1 gene.
    Type: Application
    Filed: June 14, 2004
    Publication date: March 24, 2005
    Inventors: Cezary Cybulski, Jan Lubinski, Bohdan Gorski, Bartlomiej Gliniewicz, Andrzej Sikorski, Tomasz Huzarski, Tadeusz Debniak, Jacek Gronwald, Tomasz Byrski